The cholesterol transport inhibitor U18666a regulates amyloid precursor protein metabolism and trafficking in N2aAPP "swedish" cells

Current Alzheimer Research

Volumn 5, Issue 5, 2008, Pages 448-456

  Davis Jr , Warren ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abeta; Alpha secretase; Alzheimer's disease; Amyloid precursor protein; Beta secretase; Cholesterol; Trafficking; U18666a

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CHOLESTEROL; MESSENGER RNA;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; INHIBITION KINETICS; INTRACELLULAR SPACE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STEADY STATE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANDROSTENES; ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; HUMANS; HYBRID CELLS; MICE; RNA, MESSENGER;

EID: 53549091866     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508785908900     Document Type: Article

References (33)

1. Hartmann T. Cholesterol A beta and Alzheimer's disease. Trends Neurosci 24: S45-8 (2001).
2. Yanagisawa K. Cholesterol and pathological processes in Alzheimer's disease. J Neurosci Res 70:361-6 (2002).
3. Puglielli L, Tanzi RE and Kovacs DM. Alzheimer's disease: The cholesterol connection. Nat Neurosci 6:345-51 (2003).
4. Rebeck GW. Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis. J Mol Neurosci 23:219-24 (2004).
5. Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, et al. Cholesterol and Alzheimer's disease: Clinical and experimental models suggest interactions of different genetic dietary and environmental risk factors. Curr Drug Targets 5:517-28 (2004).
6. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 273:16576-82 (1998).
7. Bodovitz S and Klein WL. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436-40 (1996).
8. Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Paoletti R, et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 322 (Pt 3):893-8 (1997).
9. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG and Simons K. Cholesterol depletion inhibits the generation of betaamyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-1(1998).
10. Kojro E, Gimpl G, Lammich S, Marz W and Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci USA 98:5815-20(2001).
11. Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, et al. Acyl-coenzyme A: Cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 3:905-12(2001).
12. Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, et al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44:227-38 (2004).
13. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, et al. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22:1679-89 (2002).
14. Lange Y, Ye J and Steck TL. Circulation of cholesterol between lysosomes and the plasma membrane. J Biol Chem 273:18915-22 (1998).
15. Thinakaran G, Teplow DB, Siman R, Greenberg B and Sisodia SS. Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. J Biol Chem 271:9390-7 (1996).
16. Perez RG, Squazzo SL and Koo EH. Enhanced release of amyloid beta-protein from codon 670/671 "Swedish" mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways. J Biol Chem 271:9100-7 (1996).
17. Sexton RC, Panini SR, Azran F and Rudney H. Effects of 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures. Biochemistry 22:5687-92 (1983).
18. Kounnas MZ, Moir RD, Rebeck GW, Bush Al, Argraves WS, Tanzi RE, et al. LDL receptor-related protein a multifunctional ApoE receptor binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-40 (1995).
19. Herz J. The LDL receptor gene family: (Un)expected signal transducers in the brain. Neuron 29:571-81 (2001).
20. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275:7410-5 (2000).
21. Sun Y, Yao J, Kim TW and Tall AR. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem 278:27688-94 (2003).
22. Koldamova R, Staufenbiel M and Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280:43224-35 (2005).
23. Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, McIsaac SA, et al. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J Biol Chem 280:43243-56 (2005).
24. Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, et al. Deletion of Abcal increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem 280:43236-42 (2005).
25. Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, et al. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem 280:4079-88 (2005).
26. Kim WS, Rahmanto AS, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, et al. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem 282:2851-61 (2007).
27. Tansley GH, Burgess BL, Bryan MT, Su Y, Hirsch-Reinshagen V, Pearce J, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein. J Lipid Res 48:1022-34 (2007).
28. Davis W, Jr, Boyd JT, He KE and Tew KD. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells. Biochim Biophys Acta 1683:89-100(2004).
29. Chen ZJ, Vulevic B, He KE, Soulika A, Davis W, Jr, Reiner PB, et al. Association of ABCA2 expression with determinants of Alzheimer's disease. FASEB J 18:1129-31 (2004).
30. Ory DS. Niemann-Pick type C: A disorder of cellular cholesterol trafficking. Biochim Biophys Acta 1529:331-9 (2000).
31. Jin LW, Shie FS, Maezawa I, Vincent I and Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 164:975-85 (2004).
32. Crameri A, Biondi E, Kuehnle K, Lutjohann D, Thelen KM, Perga S, et al. The role of seladin-l/DHCR24 in cholesterol biosynthesis APP processing and Abeta generation in vivo. EMBO J 25:432-43 (2006).
33. Koo EH and Squazzo SL. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386-9 (1994).